Table 3.
Treatment and disease related characteristics of the study participants and association with adherence to nucleos(t)ide analogues (n = 80) n (%)
| Characteristics | Patients | Optimal adherence | P value |
| Patients | 0.24 | ||
| Treatment duration > 1 yr | 16 (21.1) | 8 (53.3) | |
| Treatment duration < 1 yr | 60 (78.9) | 39 (69.9) | |
| Adherence to other prescription pills | 0.04 | ||
| Suboptimal | 11 (45.8) | 4 (40.0) | |
| Optimal | 13 (54.2) | 13 (100.0) | |
| Follow dose scheduling instructions | 0.44 | ||
| Yes | 14 (19.4) | 7 (53.8) | |
| No | 58 (80.6) | 36 (65.5) | |
| Side effect | 0.25 | ||
| Yes | 11 (13.8) | 6 (54.5) | |
| No | 66 (82.5) | 42 (68.9) | |
| Don’t know | 1 (1.3) | 0 (0.00) | |
| Believe in the therapeutic benefit of their antiviral medications | 0.29 | ||
| Yes | 64 (80) | 40 (67.8) | |
| No | 2 (2.5) | 2 (100.0) | |
| Don’t know | 12 (15.0) | 6 (50.0) | |
| Patients’ perception of their health | 0.32 | ||
| Excellent | 10 (12.5) | 8 (80.0) | |
| Very good | 23 (28.8) | 11 (52.4) | |
| Good | 32 (40) | 22 (73.3) | |
| Fair | 10 (12.5) | 6 (66.7) | |
| Poor | 3 (3.8) | 1 (33.3) | |
| Patients’ perception of their disease condition | 0.64 | ||
| Severe | 2 (2.5) | 2 (100.0) | |
| Moderate | 15 (8.8) | 11 (73.3) | |
| Mild | 36 (45.0) | 21 (61.8) | |
| Don’t know | 25 (31.3) | 8 (63.6) | |
| Complications | 0.48 | ||
| Yes | 4 (5.1) | 2 (50.0) | |
| No | 74 (94.9) | 47 (67.1) | |
| Cirrhosis- patients’ perception | 0.68 | ||
| Yes | 7 (9) | 5 (83.3) | |
| No | 55 (70.5) | 34 (65.4) | |
| Don’t know | 16 (20.5) | 10 (66.7) | |
| Use of memory aids | 0.25 | ||
| Yes | 26 (32.5) | 15 (57.7) | |
| No | 54 (67.5) | 34 (70.8) | |
| Patient understands everything the doctor says during the consultation | 0.31 | ||
| Yes | 78 (97.5) | 47 (65.3) | |
| No | 2 (2.5) | 2 (100.0) | |
| Difference in language spoken at home and at consultation with doctor | 0.04 | ||
| Same | 42 (52.5) | 30 (76.9) | |
| Different | 38 (47.5) | 19 (54.3) | |